Pfizer sales force realignment leaves others evaluating size

Share this article:
Pfizer's late 2006 sales force realignment has left the door open for other drug firms to re-evaluate their own resource levels. “Expect to see several companies follow suit in 2007,” marketing information firm Target Rx CEO Mike Luby told MM&M. Luby said pharma companies will also be looking to create the right mix of centralized and localized operations for sales forces in 2007.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.